Forvia (FRVIA) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
3 Feb, 2026Executive summary
H1 2025 sales reached €13.5 billion, up 1.1% organically, with Electronics and Seating leading growth despite a 0.4% reported decline due to currency effects.
Operating margin improved by 20bps to 5.4% of sales (€722 million), supported by cost control and transformation programs.
Net cash flow more than doubled to €418 million, driven by higher EBITDA and reduced CapEx and R&D.
Net loss of €269 million, mainly due to €136 million non-cash charge related to SYMBIO and high restructuring costs.
Full-year 2025 guidance and leverage targets for 2026 confirmed, with a new strategic plan to be presented in early 2026.
Financial highlights
Adjusted EBITDA margin rose to 13.1% (up 100bps year-over-year), with operating income at €722 million (5.4% of sales).
Net debt reduced by €193 million to €6.3 billion; leverage ratio improved to 1.8x.
CapEx intensity reduced to ~5% in H1, targeting 7% mid-term; capitalized R&D down 17% year-over-year.
Gross profit margin decreased by ~100bps to 23.1%, mainly due to lower margins in Electronics.
Net cash flow to sales improved to 3.1% from 1.5% year-over-year.
Outlook and guidance
2025 full-year guidance reiterated: sales €26.3–27.5bn, operating margin 5.2–6.0%, net cash flow ≥€655m, net debt/EBITDA ≤1.8x.
Targeting net debt/EBITDA below 1.5x in 2026, supported by asset disposals.
Automotive production expected to remain volatile, with H2 2025 production forecast slightly above H1.
Measures in place to offset anticipated tariff impacts in H2 2025.
Net cash flow guidance at least €200m for FY 2025.
Latest events from Forvia
- 2024 outlook cut; accelerated cost and China growth actions target stronger 2025 results.FRVIA
Guidance10 Mar 2026 - Margin gains, strong cash flow, and portfolio reshaping set the stage for future growth.FRVIA
Q4 2025 & CMD24 Feb 2026 - 2.7% organic sales growth, margin gains, and deleveraging progress marked H1 2024.FRVIA
Q2 20243 Feb 2026 - Q3 sales outperformed the market by 420bps, with strong order intake and margin focus.FRVIA
Q3 202419 Jan 2026 - Q1 2025 sales up 2.6% to €6.7bn, 2025 guidance confirmed amid market volatility.FRVIA
Q1 202525 Dec 2025 - Resilient 2024 results, strong cash flow, and further deleveraging targeted for 2025.FRVIA
Q4 202418 Dec 2025 - Resilient results, new CEO, and strategic focus on sustainability and deleveraging highlighted.FRVIA
AGM 202520 Nov 2025 - Stable Q3 sales and strong cost discipline support confirmed 2025 guidance amid mixed segment trends.FRVIA
Q3 202520 Oct 2025